MXCT
MaxCyte, Inc. · Healthcare
President and CEO Douglas Doerfler sold $172K of MaxCyte, Inc.
Sold$171,553
$5.72Price
30,000Shares
−8%Stake
What MXCT did after the filing
- The stock from Fri, Feb 3 close, $5.77
- −27.4%
- S&P 500, same days
- −4.1%
Measured over 30 trading days, to the Mar 20 close.
Traded Wed, Feb 1. Filed Fri, Feb 3, 11:31 AM ET, during the session. Returns use the Feb 3 close and the Mar 20 close. Not investment advice.